Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial | |
Duan, H.; Chen, X.; Li, Z.; Pang, Y.; Jing, W.; Liu, P.; Wu, T.; Cai, C.; Shi, J.; Qin, Z. | |
2019 | |
卷号 | 25期号:2页码:190-195 |
关键词 | Adverse events China Clofazimine Multidrug-resistant tuberculosis Treatment |
ISSN号 | 1198-743X |
DOI | 10.1016/j.cmi.2018.07.012 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6346297 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Duan, H.,Chen, X.,Li, Z.,et al. Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial[J],2019,25(2):190-195. |
APA | Duan, H..,Chen, X..,Li, Z..,Pang, Y..,Jing, W..,...&Xu, S..(2019).Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial.,25(2),190-195. |
MLA | Duan, H.,et al."Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial".25.2(2019):190-195. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论